Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Johanna Pruller"'
Publikováno v:
eLife, Vol 12 (2023)
Facioscapulohumeral muscular dystrophy (FSHD) is an incurable myopathy linked to the over-expression of the myotoxic transcription factor DUX4. Targeting DUX4 is the leading therapeutic approach, however, it is only detectable in 0.1–3.8% of FSHD m
Externí odkaz:
https://doaj.org/article/dd33421a7a064060bd67e70bcede832c
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-18 (2022)
Abstract WNT signalling is essential for regulating a diverse range of cellular processes. In skeletal muscle, the WNT pathway plays crucial roles in maintenance of the stem cell pool and myogenic differentiation. Focus is usually directed at examini
Externí odkaz:
https://doaj.org/article/e7eb02e9a4694e81b6c889d69f5de30b
Autor:
Philipp Heher, Massimo Ganassi, Adelheid Weidinger, Elise N. Engquist, Johanna Pruller, Thuy Hang Nguyen, Alexandra Tassin, Anne-Emilie Declèves, Kamel Mamchaoui, Christopher R.S. Banerji, Johannes Grillari, Andrey V. Kozlov, Peter S. Zammit
Publikováno v:
Redox Biology, Vol 51, Iss , Pp 102251- (2022)
Facioscapulohumeral muscular dystrophy (FSHD) is characterised by descending skeletal muscle weakness and wasting. FSHD is caused by mis-expression of the transcription factor DUX4, which is linked to oxidative stress, a condition especially detrimen
Externí odkaz:
https://doaj.org/article/d7a7b235468647e692ef74d6d5e95b8e
Autor:
Johanna Pruller, Truc Thuy Pham, Julia E. Blower, Putthiporn Charoenphun, Alessia Volpe, Kavitha Sunassee, Gregory E. D. Mullen, Philip J. Blower, Richard A. G. Smith, Michelle T. Ma
Publikováno v:
RSC Chemical Biology. 4:65-73
An indium-111-labelled peptide binds to myeloma cells, enabling SPECT imaging of myeloma cell accumulation in lungs after intravenous administration. This is the first report of a radiolabelled cell-membrane binding peptide for cell tracking.
Autor:
Johanna Pruller, Michelle T. Ma, Philipp Heher, Isabella Hofer, Peter S. Zammit, Massimo Ganassi
Publikováno v:
Cancer Gene Therapy
Rhabdomyosarcoma is a rare childhood soft tissue cancer whose cells resemble poorly differentiated skeletal muscle, expressing myogenic proteins including MYOGENIN. Alveolar rhabdomyosarcoma (ARMS) accounts for ~40% of cases and is associated with a
Autor:
Philipp Heher, Massimo Ganassi, Adelheid Weidinger, Elise N. Engquist, Johanna Pruller, Thuy Hang Nguyen, Alexandra Tassin, Anne-Emilie Declèves, Kamel Mamchaoui, Christopher R.S. Banerji, Johannes Grillari, Andrey V. Kozlov, Peter S. Zammit
Publikováno v:
Redox biology. 51
Facioscapulohumeral muscular dystrophy (FSHD) is characterised by descending skeletal muscle weakness and wasting. FSHD is caused by mis-expression of the transcription factor DUX4, which is linked to oxidative stress, a condition especially detrimen
Autor:
AV Kozlov, AE Declèves, Thuy Hang Nguyen, Alexandra Tassin, Peter S. Zammit, Johanna Pruller, Philipp Heher, Kamel Mamchaoui, EN Engquist, Johannes Grillari, A Weidinger, Massimo Ganassi
Facioscapulohumeral muscular dystrophy (FSHD) is characterised by descending skeletal muscle weakness and wasting. FSHD is caused by mis-expression of the transcription factor DUX4, which is linked to oxidative stress, a condition especially detrimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74ecf366a4b55a3092c411705a34ccdb
https://doi.org/10.1101/2021.09.08.459509
https://doi.org/10.1101/2021.09.08.459509
Autor:
Johanna Pruller, Peter S. Zammit
Publikováno v:
Cell Engineering and Regeneration ISBN: 9783319370767
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab53ccb7b2b9f75bd99d863f6719550
https://doi.org/10.1007/978-3-319-37076-7_2-1
https://doi.org/10.1007/978-3-319-37076-7_2-1
Autor:
Isabella Hofer, Massimo Ganassi, Philipp Heher, Michelle T. Ma, Peter S. Zammit, Johanna Pruller
Publikováno v:
Cancer Gene Therapy
Rhabdomyosarcoma is a rare childhood soft tissue cancer whose cells resemble poorly differentiated skeletal muscle, expressing myogenic proteins including MYOGENIN. Alveolar rhabdomyosarcoma (ARMS) accounts for ~40% of cases and is associated with a